Abbott (ABT) Q1 FY25 earnings call

Abbott delivered a strong first quarter, achieving high single-digit organic sales growth and double-digit EPS growth, reaffirming its full-year guidance despite new tariff policies. The company highlighted its diversified business model and global manufacturing network as key strengths for navigating dynamic environments and mitigating tariff impacts. Strategic investments in its pipeline, particularly in Medical Devices, continue to drive growth and innovation, positioning Abbott for sustained performance.